SEC Form 4 · accession 0001209191-18-018021

QUAKER CHEMICAL CORP · KWR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Adrian Steeples

Officer — VP & Managing Director - A/P

Period of report

Mar 6, 2018

Accepted (ET)

Mar 8, 2018 · 4:28 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000081362

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 6, 2018	M	744	$87.30	A	5,101	D
Common Stock^F1	Mar 6, 2018	S	744	$149.8398	D	4,357	D
Common Stock	Mar 6, 2018	M	1,213	$72.12	A	5,570	D
Common Stock^F2	Mar 6, 2018	S	109	$149.5686	D	5,461	D
Common Stock^F3	Mar 6, 2018	S	1,104	$150.7527	D	4,357	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F4	$87.30	Mar 6, 2018	M	744	D	—	Feb 25, 2022	Common Stock	744	0	D
Employee Stock Option (right to buy)^F5	$72.12	Mar 6, 2018	M	1,213	D	—	Feb 23, 2023	Common Stock	1,213	1,213	D

Explanation of responses

F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.52 to $150.26, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.55 to $149.775, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.62 to $151.17, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation ("Quaker"), any security holder of Quaker, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
F4The options for this grant vested in three annual installments: 745 shares on February 25, 2016; 744 shares on February 25, 2017; and 744 shares on February 25, 2018.
F5The options for this grant vest in three annual installments: 1,213 shares on February 23, 2017; 1,213 shares on February 23, 2018; and 1,213 shares on February 23, 2019.